drugset / Trial / NCT02632474
ART Drug Dosage Adjustment in HIV-infected Population
NaSingle-groupOpen-labelTreatment
Summary
The purpose of this study is to determine efficacy of the combination of low dose of Tenofovir, Efavirenz and Lamivudine in treating HIV-infection.
Timeline
- Start
- 2015-04
- Primary completion
- 2016-12
- Completion
- —
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Efavirenz | Other / unclassified | 400 mg | — |
| Subject | Efavirenz | Other / unclassified | 600 mg | — |
| Subject | Lamivudine | Other / unclassified | 300 mg | — |
| Subject | Tenofovir | Small molecule | 200 mg | — |
| Subject | Tenofovir | Small molecule | 300 mg | — |